SlideShare a Scribd company logo

Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?

•Download as PPT, PDF•
•
PeerVoice
PeerVoice

Xavier Montalban, MD, PhD, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CE activity titled "Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?" For the full presentation, please visit us at www.peervoice.com/BBT870.

Health & Medicine
1 of 20
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?

Recommended

The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...PeerVoice
 
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaPeerVoice
 
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...PeerVoice
 

Recommended

The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...PeerVoice
 
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaPeerVoice
 
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...PeerVoice
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...PeerVoice
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...PeerVoice
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...PeerVoice
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...PeerVoice
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...PeerVoice
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...PeerVoice
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...PeerVoice
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...PeerVoice
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...PeerVoice
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...PeerVoice
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023PeerVoice
 
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...PeerVoice
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesTina Purnat
 

More Related Content

More from PeerVoice

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...PeerVoice
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...PeerVoice
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...PeerVoice
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...PeerVoice
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...PeerVoice
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...PeerVoice
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...PeerVoice
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...PeerVoice
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...PeerVoice
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...PeerVoice
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023PeerVoice
 
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...PeerVoice
 

More from PeerVoice (20)

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
 
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
 

Recently uploaded

Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesTina Purnat
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMeenakshiGursamy
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartMedicoseAcademics
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgeryKafrELShiekh University
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxDr. Dheeraj Kumar
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Dr. Aryan (Anish Dhakal)
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediatesdorademei
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxKhanSabit
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyDr KHALID B.M
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCatherine Liao
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxBright Chipili
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Anjali Parmar
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxgauripg8
 

Recently uploaded (20)

Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx